Development and validation of an interpretable machine learning model for predicting early acute kidney injury and altered consciousness in cardiac surgery patients admitted to the intensive care unit: a retrospective study.

IF 5.7 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Frontiers in Endocrinology Pub Date : 2026-10-07 eCollection Date: 2026-01-01 DOI:10.3389/fendo.2026.1959304
Shu Yang, Jing Luo, Lianzheng Ma, Dongxiao Huang, Minmin Zhu, Linlin Cai
{"title":"Development and validation of an interpretable machine learning model for predicting early acute kidney injury and altered consciousness in cardiac surgery patients admitted to the intensive care unit: a retrospective study.","authors":"Shu Yang, Jing Luo, Lianzheng Ma, Dongxiao Huang, Minmin Zhu, Linlin Cai","doi":"10.3389/fendo.2026.1959304","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute kidney injury (AKI) and altered consciousness are common and serious complications following cardiac surgery, both associated with increased morbidity and mortality in the intensive care unit (ICU). Early prediction of these complications is essential for timely intervention. We aimed to develop and validate an interpretable machine learning model for predicting early AKI and altered consciousness risk in this population.</p><p><strong>Methods: </strong>We retrospectively extracted data from the MIMIC-IV database. Adult patients who underwent cardiac surgery within 24 h before ICU admission were included. The primary outcome was early AKI defined by KDIGO criteria within 48 h after ICU admission. The secondary outcome was altered consciousness within 24 h after ICU admission, defined as a Glasgow Coma Scale (GCS) score ≤12. A comprehensive set of candidate variables was screened using four feature selection methods (LassoCV, mRMR, mutual information, and <i>F</i>-test) with a voting strategy. Eight machine learning models were developed and compared. SHapley Additive exPlanations (SHAP) values were used to interpret the best-performing model. External validation was performed using data from cardiac surgery patients at Wuxi No.2 People's Hospital between 1 January 2020 and 31 December 2025.</p><p><strong>Result: </strong>A total of 5,288 patients were included, with an AKI incidence of 76.2% (4,031/5,288) and an altered consciousness incidence of 22.8% (1,206/5,288). For the primary outcome of AKI, the XGBoost model achieved a training AUC of 0.787 (95% CI: 0.770-0.804) and an internal test AUC of 0.659 (95% CI: 0.629-0.688). For the secondary outcome of altered consciousness, the XGBoost model achieved an internal test AUC of 0.951 (95% CI: 0.936-0.963). Calibration curve and decision curve analysis confirmed good calibration and clinical utility for both models. SHAP analysis identified SpO<sub>2</sub>, age, APSIII score, creatinine, and white blood cell count as the top 5 most important predictors for AKI. External validation was performed in an independent cohort of 395 cardiac surgery ICU patients from Wuxi No.2 People's Hospital, in whom the incidence of AKI and altered consciousness was 28.1% and 67.3%, respectively. The models retained acceptable discrimination in this external cohort (AKI: AUC 0.764, 95% CI: 0.711-0.818; altered consciousness: AUC 0.679, 95% CI: 0.615-0.737).</p><p><strong>Conclusion: </strong>We developed interpretable XGBoost-based prediction models for both early AKI and altered consciousness risk in cardiac surgery patients admitted to the ICU. The models exhibited excellent discrimination, calibration, and clinical utility, which may facilitate early identification of high-risk patients and guide personalized interventions.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"17 ","pages":"1959304"},"PeriodicalIF":5.7000,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13682982/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fendo.2026.1959304","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acute kidney injury (AKI) and altered consciousness are common and serious complications following cardiac surgery, both associated with increased morbidity and mortality in the intensive care unit (ICU). Early prediction of these complications is essential for timely intervention. We aimed to develop and validate an interpretable machine learning model for predicting early AKI and altered consciousness risk in this population.

Methods: We retrospectively extracted data from the MIMIC-IV database. Adult patients who underwent cardiac surgery within 24 h before ICU admission were included. The primary outcome was early AKI defined by KDIGO criteria within 48 h after ICU admission. The secondary outcome was altered consciousness within 24 h after ICU admission, defined as a Glasgow Coma Scale (GCS) score ≤12. A comprehensive set of candidate variables was screened using four feature selection methods (LassoCV, mRMR, mutual information, and F-test) with a voting strategy. Eight machine learning models were developed and compared. SHapley Additive exPlanations (SHAP) values were used to interpret the best-performing model. External validation was performed using data from cardiac surgery patients at Wuxi No.2 People's Hospital between 1 January 2020 and 31 December 2025.

Result: A total of 5,288 patients were included, with an AKI incidence of 76.2% (4,031/5,288) and an altered consciousness incidence of 22.8% (1,206/5,288). For the primary outcome of AKI, the XGBoost model achieved a training AUC of 0.787 (95% CI: 0.770-0.804) and an internal test AUC of 0.659 (95% CI: 0.629-0.688). For the secondary outcome of altered consciousness, the XGBoost model achieved an internal test AUC of 0.951 (95% CI: 0.936-0.963). Calibration curve and decision curve analysis confirmed good calibration and clinical utility for both models. SHAP analysis identified SpO2, age, APSIII score, creatinine, and white blood cell count as the top 5 most important predictors for AKI. External validation was performed in an independent cohort of 395 cardiac surgery ICU patients from Wuxi No.2 People's Hospital, in whom the incidence of AKI and altered consciousness was 28.1% and 67.3%, respectively. The models retained acceptable discrimination in this external cohort (AKI: AUC 0.764, 95% CI: 0.711-0.818; altered consciousness: AUC 0.679, 95% CI: 0.615-0.737).

Conclusion: We developed interpretable XGBoost-based prediction models for both early AKI and altered consciousness risk in cardiac surgery patients admitted to the ICU. The models exhibited excellent discrimination, calibration, and clinical utility, which may facilitate early identification of high-risk patients and guide personalized interventions.

开发和验证可解释的机器学习模型,用于预测重症监护病房心脏手术患者的早期急性肾损伤和意识改变:一项回顾性研究。
背景:急性肾损伤(AKI)和意识改变是心脏手术后常见且严重的并发症,两者都与重症监护病房(ICU)的发病率和死亡率增加有关。早期预测这些并发症对于及时干预至关重要。我们的目标是开发和验证一个可解释的机器学习模型,用于预测这一人群的早期AKI和意识改变风险。方法:我们回顾性地从MIMIC-IV数据库中提取数据。纳入入院前24小时内接受心脏手术的成年患者。主要终点是ICU入院后48小时内由KDIGO标准定义的早期AKI。次要结局为ICU入院后24小时内意识改变,定义为格拉斯哥昏迷量表(GCS)评分≤12。采用四种特征选择方法(LassoCV、mRMR、互信息和f检验)和投票策略筛选综合候选变量集。开发并比较了8种机器学习模型。SHapley加性解释(SHAP)值被用来解释表现最好的模型。外部验证使用的数据来自无锡市第二人民医院2020年1月1日至2025年12月31日期间的心脏手术患者。结果:共纳入5288例患者,AKI发生率为76.2%(4031 / 5288),意识改变发生率为22.8%(1206 / 5288)。对于AKI的主要结局,XGBoost模型的训练AUC为0.787 (95% CI: 0.70 -0.804),内部测试AUC为0.659 (95% CI: 0.629-0.688)。对于意识改变的次要结局,XGBoost模型的内部检验AUC为0.951 (95% CI: 0.936-0.963)。校正曲线和决策曲线分析证实两种模型具有良好的校正效果和临床应用价值。SHAP分析发现SpO2、年龄、APSIII评分、肌酐和白细胞计数是AKI的前5个最重要的预测因子。外部验证在无锡市第二人民医院395例心外科ICU患者中进行,其中AKI和意识改变的发生率分别为28.1%和67.3%。该模型在该外部队列中保留了可接受的区分(AKI: AUC 0.764, 95% CI: 0.711-0.818;改变意识:AUC 0.679, 95% CI: 0.615-0.737)。结论:我们建立了可解释的基于xgboost的预测模型,用于ICU住院的心脏手术患者的早期AKI和意识改变风险。该模型具有良好的识别、校准和临床实用性,有助于早期识别高危患者并指导个性化干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Endocrinology
Frontiers in Endocrinology Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
5.70
自引率
9.60%
发文量
3023
审稿时长
14 weeks
期刊介绍: Frontiers in Endocrinology is a field journal of the "Frontiers in" journal series. In today’s world, endocrinology is becoming increasingly important as it underlies many of the challenges societies face - from obesity and diabetes to reproduction, population control and aging. Endocrinology covers a broad field from basic molecular and cellular communication through to clinical care and some of the most crucial public health issues. The journal, thus, welcomes outstanding contributions in any domain of endocrinology. Frontiers in Endocrinology publishes articles on the most outstanding discoveries across a wide research spectrum of Endocrinology. The mission of Frontiers in Endocrinology is to bring all relevant Endocrinology areas together on a single platform.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书